Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Asset Writedowns and Impairment: 2012-2024

Historic Asset Writedowns and Impairment for ProPhase Labs (PRPH) over the last 2 years, with Dec 2024 value amounting to $11.0 million.

  • ProPhase Labs' Asset Writedowns and Impairment rose 183533.33% to $11.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $11.7 million, marking a year-over-year increase of 557.78%. This contributed to the annual value of $11.0 million for FY2024, which is 1421.82% up from last year.
  • According to the latest figures from Q4 2024, ProPhase Labs' Asset Writedowns and Impairment is $11.0 million, which was up 183,533.33% from $6,000 recorded in Q4 2023.
  • ProPhase Labs' Asset Writedowns and Impairment's 5-year high stood at $11.0 million during Q4 2024, with a 5-year trough of -$3.3 million in Q4 2022.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $273,000 (2022), whereas its average is $1.4 million.
  • In the last 5 years, ProPhase Labs' Asset Writedowns and Impairment tumbled by 70.30% in 2023 and then soared by 183,533.33% in 2024.
  • Quarterly analysis of 3 years shows ProPhase Labs' Asset Writedowns and Impairment stood at -$3.3 million in 2022, then spiked by 100.18% to $6,000 in 2023, then spiked by 183,533.33% to $11.0 million in 2024.
  • Its Asset Writedowns and Impairment was $11.0 million in Q4 2024, compared to $6,000 in Q4 2023 and $865,000 in Q2 2023.